We are live on ! Find out more
TPC

Takeda Pharmaceutical Company Portfolio holdings

AUM $16.4M
1-Year Est. Return 195.92%
This Fund
S&P 500
This Quarter Est. Return
+6.99%
1 Year Est. Return
+195.92%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$289M
AUM Growth
-$38.5M
Cap. Flow
-$40.7M
Cap. Flow %
-14.08%
Top 10 Hldgs %
98.97%
Holding
15
New
1
Increased
–
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
DAWN
Day One Biopharmaceuticals
DAWN
+$1.28M

Top Sells

Rank Stock Value
1
PHAT icon
Phathom Pharmaceuticals
PHAT
+$36.6M
2
STTK icon
Shattuck Labs
STTK
+$5.4M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HLVX
1
DELISTED
HilleVax
HLVX
$112M 38.69%
6,724,000
– –
DNLI icon
2
Denali Therapeutics
DNLI
$3.84B
$86.5M 29.92%
4,214,559
– –
PHAT icon
3
Phathom Pharmaceuticals
PHAT
$666M
$33.5M 11.59%
3,153,217
-4,306,069
-58% -$36.6M
OVID icon
4
Ovid Therapeutics
OVID
$489M
$23M 7.95%
7,531,996
– –
STTK icon
5
Shattuck Labs
STTK
$704M
$13.4M 4.64%
1,501,061
-589,797
-28% -$5.4M
WVE icon
6
Wave Life Sciences
WVE
$1.17B
$8.31M 2.88%
1,346,892
– –
EQ icon
7
Equillium
EQ
$138M
$4.22M 1.46%
1,824,977
– –
TSBX
8
DELISTED
Turnstone Biologics
TSBX
$2.35M 0.81%
895,824
– –
XLO icon
9
Xilio Therapeutics
XLO
$59.9M
$1.59M 0.55%
105,366
– –
DAWN
10
DELISTED
Day One Biopharmaceuticals
DAWN
$1.42M 0.49%
+85,840
New +$1.28M
AMWL icon
11
American Well
AMWL
$221M
$1.26M 0.44%
77,733
– –
RANI icon
12
Rani Therapeutics
RANI
$87.7M
$1.05M 0.36%
338,679
– –
JBIO
13
Jade Biosciences
JBIO
$1.32B
$402K 0.14%
388
– –
AKLI
14
DELISTED
Akili Inc
AKLI
$214K 0.07%
738,819
– –
LAB icon
15
Standard BioTools
LAB
$307M
$44.8K 0.02%
16,515
– –

Similar funds

KL
KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return
LM
Lasry Marc $15.1M AUM 10.39% 1-Year Est. Return
DADR
Dynamo Administracao de Recursos Rio De Janeiro, Brazil $18.5M AUM 37.41% 1-Year Est. Return
AVM
Avalon Ventures Management La Jolla, California $14.2M AUM 9.35% 1-Year Est. Return
RCMU
Rokos Capital Management (US) New York $14.2M AUM
PM
Pharo Management New York $18.7M AUM
SHM
Sagard Holdings Management Toronto, Ontario, Canada $20M AUM
SI
SQN Investors Menlo Park, California $12.8M AUM

Takeda Pharmaceutical Company's Q1 2024 Portfolio in Review

As of Q1 2024, Takeda Pharmaceutical Company held 15 positions worth $289M, down 12% from $327M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Takeda Pharmaceutical Company withdrew a net $40.7M in Q1 2024, reducing 2 holdings. Its largest reduction was Phathom Pharmaceuticals, cutting an estimated $36.6M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Takeda Pharmaceutical Company opened a new position in Day One Biopharmaceuticals worth $1.42M.

  • Takeda Pharmaceutical Company's largest Q1 2024 buy was Day One Biopharmaceuticals: 85,840 shares worth $1.42M.
  • Takeda Pharmaceutical Company's biggest Q1 2024 reduction was Phathom Pharmaceuticals, cutting an estimated $36.6M.
  • Takeda Pharmaceutical Company's ten largest holdings make up 99% of its $289M portfolio in Q1 2024.
  • Takeda Pharmaceutical Company opened 1 new position and closed 0 in Q1 2024.
  • Takeda Pharmaceutical Company's portfolio value fell 12% quarter-over-quarter to $289M.

Based on Takeda Pharmaceutical Company's 13F filing for Q1 2024, filed 13 Feb 2025.